Related Experiment Video
Updated: Mar 16, 2026
07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
10.4K
Management of Breast Sarcoma
Cary Hsu1, Susan A McCloskey2, Parvin F Peddi3
1Department of Surgery, Baylor College of Medicine, One Baylor Plaza, MS 390, Houston, TX 77030, USA.
The Surgical Clinics of North America
|August 21, 2016
Summary
Breast sarcomas are rare. Treatment focuses on wide surgical margins, with breast-conserving surgery and reconstruction considered for select patients. Adjuvant therapies are reserved for high-risk cases.
Area of Science:
- Oncology
- Surgical Oncology
- Pathology
Background:
- Breast sarcomas are rare mesenchymal neoplasms with diverse histologic subtypes.
- Management principles are derived from extremity sarcoma protocols.
- Anatomic location impacts treatment decisions, especially surgical approaches.
Purpose of the Study:
- To outline current therapeutic strategies for breast sarcomas.
- To emphasize the importance of surgical margins in breast sarcoma management.
- To discuss the role of breast-conserving surgery and reconstruction.
Main Methods:
- Review of established principles in sarcoma management.
- Application of these principles to the specific context of breast sarcomas.
- Consideration of surgical, radiation, and chemotherapeutic modalities.
Main Results:
- Surgical management aims for widely negative margins.
- Breast-conserving surgery is feasible for selected patients.
- Breast reconstruction is an option for appropriate candidates.
Conclusions:
- Optimal surgical resection with wide negative margins is paramount.
- Multidisciplinary treatment decisions are guided by tumor characteristics and patient factors.
- Adjuvant therapies (radiation, chemotherapy) are selectively employed for high-grade or advanced-stage breast sarcomas.
